Amylyx Pharmaceuticals, Inc. (AMLX)

Import this data to Google Sheets with:

=jivedata("AMLX","financials")

Full statements spill as a table. For one cell: =jivedata("AMLX","Revenue") or =jivedata("AMLX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Amylyx Pharmaceuticals, Inc.

AMLX • CIK 0001658551

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$380,786	—	—	$380,786
Revenue from Contract with Customer, Excluding Assessed Tax	$380,786	$87,371	$0	$0
Cost of Goods and Services Sold	$25,441	$5,953	$0	$0
Selling, General and Administrative Expense	$188,356	$114,331	$62,887	$69,656
Research and Development Expense	$128,187	$104,084	$90,404	$92,447
Operating Income (Loss)	$38,802	$-314,731	$-153,291	$-162,103
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$54,297	$-302,136	$-144,689	$-144,689
Income Tax Expense (Benefit)	$5,026	$-393	$46	$46
Net Income (Loss) Attributable to Parent	$49,271	$-301,743	$-144,735	$-152,092

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$517,454	$193,634	$332,645	$264,564
Liabilities	$84,022	$28,869	$27,386	$25,397
Assets, Current	$464,666	$189,432	$323,671	$256,338
Cash and Cash Equivalents, at Carrying Value	$170,201	$77,391	$226,651	$49,326
Short-term Investments	$201,161	—	—	$234,813
Accounts Receivable, after Allowance for Credit Loss, Current	$40,050	$447	$88	$88
Inventory, Net	$38,323	$38,323	—	$38,323
Property, Plant and Equipment, Net	$2,686	$961	$310	$199
Property, Plant and Equipment, Gross	$4,314	$2,320	$1,864	$1,864
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$1,628	$1,359	$1,554	$1,554
Operating Lease, Right-of-Use Asset	$3,725	$1,771	$5,181	$4,541
Deferred Tax Assets, Net of Valuation Allowance	$1,552	$607	$1,429	$1,429
Other Assets, Noncurrent	$701	$24	—	$2,500
Liabilities, Current	$82,042	$28,406	$22,688	$21,150
Accounts Payable, Current	$22,061	$2,939	$3,519	$5,533
Accrued Liabilities, Current	$57,724	$23,949	$17,910	$14,609
Stockholders' Equity Attributable to Parent	$433,432	$164,765	$305,259	$239,167

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Cash Provided by (Used in) Operating Activities	$11,919	$-167,647	$-123,343	$-126,577
Net Cash Provided by (Used in) Investing Activities	$92,053	$75,654	$14,039	$-78,831
Net Cash Provided by (Used in) Financing Activities	$3,543	$348	$257,029	$196,094
Payments to Acquire Property, Plant, and Equipment	$1,241	$157	$138	$140

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("AMLX","financials")

Full statements spill as a table. For one cell: =jivedata("AMLX","Revenue") or =jivedata("AMLX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.